The store will not work correctly when cookies are disabled.
4-nitrophenyl benzenesulfonate
ID: ALA4854613
Cas Number: 3313-84-6
PubChem CID: 347803
Max Phase: Preclinical
Molecular Formula: C12H9NO5S
Molecular Weight: 279.27
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=[N+]([O-])c1ccc(OS(=O)(=O)c2ccccc2)cc1
Standard InChI: InChI=1S/C12H9NO5S/c14-13(15)10-6-8-11(9-7-10)18-19(16,17)12-4-2-1-3-5-12/h1-9H
Standard InChI Key: KAHNIMUVMKNJPX-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
13.5125 -9.3606 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.1081 -8.6548 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
12.6991 -9.3580 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.2795 -8.6671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2784 -9.4867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9864 -9.8956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6961 -9.4862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6932 -8.6635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9846 -8.2583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3994 -8.2523 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.8148 -8.2470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5225 -8.6563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2282 -8.2457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2255 -7.4276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5113 -7.0219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8085 -7.4348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5684 -9.8985 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.5678 -10.7157 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.8610 -9.4893 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
8 10 1 0
10 2 1 0
2 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
17 18 2 0
17 19 1 0
5 17 1 0
M CHG 2 17 1 19 -1
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 279.27 | Molecular Weight (Monoisotopic): 279.0201 | AlogP: 2.36 | #Rotatable Bonds: 4 |
Polar Surface Area: 86.51 | Molecular Species: ┄ | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.13 | CX LogD: 3.13 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.49 | Np Likeness Score: -1.19 |
References
1. Parsons WH, Rutland NT, Crainic JA, Cardozo JM, Chow AS, Andrews CL, Sheehan BK.. (2021) Development of succinimide-based inhibitors for the mitochondrial rhomboid protease PARL., 49 [PMID:34311087] [10.1016/j.bmcl.2021.128290] |